Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|January 1, 2008
Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activatorMartyn Frederickson, Owen Callaghan, Gianni Chessari, et al.
Journal of Medicinal Chemistry|February 17, 2006
Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitorsNigel Howard, Chris Abell, Wendy Blakemore, et al.
Journal of Medicinal Chemistry|January 19, 2012
Identification of novel adenosine A(2A) receptor antagonists by virtual screeningChristopher J Langmead, Stephen P Andrews, Miles Congreve, et al.
Structure (London, England : 1993)|September 3, 2011
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeineAndrew S Doré, Nathan Robertson, James C Errey, et al.
Journal of Medicinal Chemistry|January 7, 2012
Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug designMiles Congreve, Stephen P Andrews, Andrew S Doré, et al.
Journal of Medicinal Chemistry|March 23, 2013
Biophysical fragment screening of the β1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug designJohn A Christopher, Jason Brown, Andrew S Doré, et al.
Nature|December 8, 2016
Intracellular allosteric antagonism of the CCR9 receptorChristine Oswald, Mathieu Rappas, James Kean, et al.
Journal of Medicinal Chemistry|February 24, 2007
Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretaseMiles Congreve, David Aharony, Jeffrey Albert, et al.
Chemmedchem|March 12, 2014
Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocketSusanne M Saalau-Bethell, Valerio Berdini, Anne Cleasby, et al.
Pageof 6